Medical Corporation Mikikai Sun Field Clinic, located in Aomi, Koto-ku, Tokyo, is a medical institution that, while specializing in internal medicine, also engages in advanced regenerative medicine. The clinic has obtained a Type 2 Regenerative Medicine Provision Plan number after passing the review of a Specific Certified Regenerative Medicine Committee approved by the Ministry of Health, Labour and Welfare, and has been providing treatments using autologous adipose-derived mesenchymal stem cells since 2011. Specifically, the clinic offers stem cell therapy aimed at preventing the progression of arteriosclerosis and alleviating chronic pain, as well as culture supernatant therapy and IV drip/injection treatments for anti-aging purposes. The medical team includes Director Keiji Tanikawa, a graduate of the National Defense Medical College, along with surgical specialists, Chief Doctor Ritsuo Kokubu from Nippon Medical School, and Chief Advisor Yuki Ota, a Doctor of Medicine from The Jikei University School of Medicine who belongs to the Regenerative Medicine Research Department. The clinic offers consultations on weekday and Saturday mornings and afternoons, with parking facilities and barrier-free access. Multiple payment methods including credit cards, debit cards, and electronic payments are accepted, providing a user-friendly environment.